<DOC>
	<DOCNO>NCT00002650</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention therapy use certain drug try prevent development recurrence cancer . The use folic acid may effective way prevent colorectal cancer patient polyps surgically remove . PURPOSE : Randomized phase II trial study effectiveness high-dose folic acid prevent colorectal cancer patient polyps surgically remove within 18 month trial .</brief_summary>
	<brief_title>High-Dose Folic Acid Preventing Colorectal Cancer Patients Who Have Had Polyps Surgically Removed</brief_title>
	<detailed_description>OBJECTIVES : I . Determine whether high-dose folic acid decrease global DNA hypomethylation , well intermediary marker , normal-appearing colonic epithelium patient colonic adenoma . II . Determine whether decrease global DNA hypomethylation intermediary marker induce safely whether effect persist folic acid discontinue patient . III . Confirm pilot data indicate patient adenomas widespread DNA hypomethylation colorectal mucosa compare control . IV . Evaluate effect folic acid clinical course rate recurrence adenomatous polyp patient . V. Study control group patient history neoplastic , hyperplastic , inflammatory colorectal lesion . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Patients stratify accord participate center age ( 50-70 v 30-49 70 ) . Patients adenomatous polyp least 10 mm colonoscopy randomize 1 2 treatment arm . Patients find neoplastic , hyperplastic , inflammatory polyp colonoscopy assign control ( untreated ) group complete laboratory study baseline food frequency questionnaire . Arm I : Patients receive folic acid daily . Arm II : Patients receive placebo daily . Treatment continue arm 1 year absence unacceptable toxicity disease progression . Patients follow 1 year . PROJECTED ACCRUAL : A total 80 patient ( 30 per arm 20 control group ) accrue study within 24 month .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Colonic adenoma ( ) least 10 mm completely resect within 18 month prior randomization suspect adenomatous polyp ( ) Colonoscopy submission least 7 rectosigmoid biopsy require entry No benign hyperplastic polyp polyps less 10 mm eligible treatment No polyposis coli ( i.e. , 100 polyp colon ) No history invasive colorectal cancer PATIENT CHARACTERISTICS : Age : 21 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Platelet count great 100,000/mm3 Hemoglobin great 10 g/dL No untreated pernicious anemia Hepatic : Bilirubin le 2 mg/dL ALT le 2 time normal Alkaline phosphatase less 2 time normal PT normal Renal : Not specify Gastrointestinal : No intestinal malabsorption No inflammatory bowel disease Other : No seizure within past year No poor medical risk No malignancy within past 5 year except basal cell cancer , superficial skin cancer , carcinoma situ cervix No vitamin B12 deficiency ( le 200 pg/mL ) Not pregnant nursing Fertile patient must use effective barrier contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No concurrent methotrexate Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : See Disease Characteristics No prior small bowel resection Other : No concurrent anticonvulsants No concurrent drug markedly interfere folate absorption metabolism ( e.g. , sulfasalazine phenytoin ) No concurrent vitamins 2 year begin study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>colon cancer</keyword>
	<keyword>rectal cancer</keyword>
</DOC>